Home › Funds › GREAT POINT PARTNERS LLC › AMLX

GREAT POINT PARTNERS LLC position in AMLX

AMYLYX PHARMACEUTICALS INC · Health Care

GREAT POINT PARTNERS LLC reported holding 700,000 shares of AMLX (AMYLYX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$12.6M, representing 2.64% of its reported portfolio and ranking #17 among its reported holdings. GREAT POINT PARTNERS LLC has disclosed AMLX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)700.00K sh
Reported value held$12.57M
Portfolio Weight2.64%
First reportedQ1 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How GREAT POINT PARTNERS LLC's AMLX position evolved

GREAT POINT PARTNERS LLC first disclosed a stake in AMLX in Q1 2025 at 1,811,996 shares (US$6.4M). The position peaked in Q1 2026 at 1,750,000 shares, worth US$24.3M. Across 6 filings, GREAT POINT PARTNERS LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 700,000 shares valued at US$12.6M — a reduction of -1,050,000 shares quarter over quarter.. Notable position changes include a 60% trim in Q2 2026 (shares rose 62% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 1.81M $6.41M New
Q2 2025 2.00M $12.82M Add
Q3 2025 1.70M $23.10M Reduce
Q4 2025 1.75M $21.14M Add
Q1 2026 1.75M $24.32M Hold
Q2 2026 700.00K $12.57M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMLX and 13F data

AMLX (AMYLYX PHARMACEUTICALS INC) is a Health Care company. 50 other funds we track also report a position in AMLX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$149.7M), TCG Crossover Management, LLC (US$112.1M), Commodore Capital LP (US$101.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMLX

All AMLX fund holders →

FAQ

How long has GREAT POINT PARTNERS LLC held AMLX?

GREAT POINT PARTNERS LLC has disclosed AMLX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is GREAT POINT PARTNERS LLC's current position in AMLX?

As of Q2 2026, GREAT POINT PARTNERS LLC holds 700.00K shares of AMLX (AMYLYX PHARMACEUTICALS INC), valued at $12.57M, representing 2.64% of its reported portfolio and ranking #17.

Has GREAT POINT PARTNERS LLC been buying or selling AMLX?

In the latest 13F filing (Q2 2026), GREAT POINT PARTNERS LLC reduced its position in AMLX. The position peaked in Q1 2026 at 1.75M shares.

Which other funds hold AMLX?

Other major institutional holders of AMLX include PERCEPTIVE ADVISORS LLC, TCG Crossover Management, LLC, Commodore Capital LP, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.